“…While a strong antibody response contributes to the control of acute parasitemia, a potent type 1 cytokine production and a CD8 ϩ T cell-mediated response are largely responsible for the immune control of tissue parasites (4). That CD8 ϩ T cells are of critical importance in resistance to T. cruzi is supported by their predominance in inflammatory foci of parasitized tissues (5)(6)(7)(8), by the correlation between failure to survive the acute stage of infection, increased tissue parasite loads and an absent inflammatory response in mice made deficient of this T cell subset (9)(10)(11), and by the ability of CD8 ϩ T cells from infected mice to act as cytotxic T lymphocytes (CTL) 1 against T. cruzi -infected cells (12). Recent efforts to elucidate the molecules contributing to such MHC class I-restricted responses have led to the identification of amastigote surface protein (ASP)-1 and ASP-2, two surface proteins on the intracellular amastigote stage (13,14), and trypomastigote surface protein (TSA)-1, a surface antigen on the cell-invasive trypomastigote form (15), as the first bona fide targets of CTL in T. cruzi -infected mice (16,17).…”